# Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)

> **NCT00125645** · PHASE4 · COMPLETED · sponsor: **University of Southern Denmark** · enrollment: 200 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Irbesartan Oral Tablet

## Key facts

- **NCT ID:** NCT00125645
- **Lead sponsor:** University of Southern Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03-01
- **Primary completion:** 2011-09-01
- **Final completion:** 2011-09-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2018-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125645, "Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00125645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*